24/7/10
News headlines 20th June to 23rd July 2010
‘Curis
Tumbles on Failure of Cancer Drug Trial: Biotech's Latest Mishaps.’
Bullfax. 20 June 2010.
‘Pfizer
pulls leukemia drug from U.S. market.
Drugmaker Pfizer Inc is pulling a decade-old leukemia medicine off the U.S.
market after a study found a higher death rate and no benefit for patients.’
Reuters. 21 June 2010.
'Mylotarg
(gemtuzumab ozogamicin): Market Withdrawal.'
FDA Medwatch. 21 June 2010.
‘Pfizer
Suspends Trial of Tanezumab for Osteoarthritis Pain at U.S. Request’
Bloomberg. 23 June 2010.
‘Glaxo
Settles Nearly 200 Paxil Birth Defect Lawsuits.’
Pharmalot. 23 June 2010.
'Pfizer
shares fall over problems with pain drug.'
Bloomberg Business Week. 24 June 2010
'EU
regulators probe risks of blood pressure drugs.'
Reuters. 25 June 2010
'Study
raises questions over wider use of statins.'
Reuters. 28 June 2010
'Lilly’s
Effient Tied to More Cancer Risk Than Plavix.'
Bloomberg Business Week. 28 June 2010
‘Merck
to fight $8M Fosamax verdict.
Merck has lost its first Fosamax jury trial. A New York jury awarded
$8 million in damages to plaintiff Shirley Boles, who claimed her osteonecrosis
of the jaw was caused by the bone-building drug.’
Fiercepharma. 28 June 2010
'US
FDA probes possible risks of Lilly drug, others. Lilly's Effient,
Sanofi's Multaq under review.'
Reuters. 30 June 2010
'Rosiglitazone
is linked to heart failure, stroke, and death.'
BMJ. 1 July 2010, JAMA 2010; doi:10.1001/jama.2010.920. Arch Intern
Med 2010;
doi:10.1001/archinternmed.2010.207
‘Testosterone
Gel Trial Ends After Heart Issue’
New York Times. 5 July 2010.
‘Second
big setback for XenoPort: Migraine drug fails test.’
Mercury News. 7 July 2010.
‘Warning
on Liver Injury with Propylthiouracil.’
FDA. July 2010.
‘Glaxo,
Xenoport migraine drug fails, shares fall.’
Reuters. 7 July 2010.
‘Arava
(leflunomide): Boxed Warning - Risk of Severe Liver Injury.’
FDA. 13 July 2010.
‘Glaxo
pays $460 million to resolve Avandia suits. It was facing more than 13,000
claims alleging that it hid the diabetes drug's heart-attack risk.’
Philadelphia Inquirer. 14 July 2010.
‘Glaxosmithkline to settle claims. GlaxoSmithKline will post a record
£1.57billion legal charge during the second quarter
GlaxoSmithKline will post a record £1.57billion legal charge during
the second quarter to settle a host of claims relating to blockbuster
diabetes pill Avandia and depression treatment Paxil.’
Daily Express. 16 July 2010.
‘FDA
panel rejects diet drug.’s
Post-Gazette. 16 July 2010.
‘Promising
Breast Cancer Drug Fails FDA Test. New Study Shows Little Result Compared
To Chemotherapy Alone.’ FoxReno. 19 July 2010‘Pfizer forced
to halt pain drug trials.’
Inpharm. 20 July 2010
‘Glaxo
says settles some Paxil birth-defect cases.’
Reuters. 20 July 2010
‘Trials of 'unsafe' drug for diabetes stopped.’
Times of India. 23 July 2010.
See
the new VIN website: http://www.vivisectioninformation.com
Information for abolition
Related Articles:
